David J Mooney Selected Research

Alginates

1/2021	A novel two-component, expandable bioadhesive for exposed defect coverage: Applicability to prenatal procedures.
11/2020	Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors.
1/2018	Injectable, Tough Alginate Cryogels as Cancer Vaccines.
1/2018	CD4 T-cells regulate angiogenesis and myogenesis.
3/2017	Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
1/2017	VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits.
6/2015	Alginate and DNA Gels Are Suitable Delivery Systems for Diabetic Wound Healing.
8/2014	Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.
12/2013	Ca(2+) released from calcium alginate gels can promote inflammatory responses in vitro and in vivo.
9/2012	Highly stretchable and tough hydrogels.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Mooney Research Topics

Disease

44	Neoplasms (Cancer) 12/2022 - 10/2007
14	Wounds and Injuries (Trauma) 11/2022 - 01/2011
11	Ischemia 01/2019 - 07/2005
7	Inflammation (Inflammations) 10/2022 - 12/2013
7	Melanoma (Melanoma, Malignant) 01/2018 - 11/2009
6	Infections 01/2022 - 08/2013
5	Fibrosis (Cirrhosis) 01/2021 - 06/2009
3	Hypoxia (Hypoxemia) 01/2022 - 03/2007
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2015 - 03/2003
3	Necrosis 01/2013 - 03/2007
2	Bites and Stings (Sting) 12/2022 - 02/2017
2	Rupture 10/2022 - 09/2012
2	Cicatrix (Scar) 10/2022 - 01/2016
2	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2020
2	Diabetes Mellitus 01/2022 - 06/2015
2	Sepsis (Septicemia) 01/2022 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 03/2017
2	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2017 - 01/2017
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2017 - 10/2007
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 12/2014
2	Ulcer 01/2016 - 12/2013
2	Myocardial Infarction 08/2014 - 07/2007
2	Infarction (Infarctions) 08/2014 - 04/2006
2	Glioma (Gliomas) 09/2011 - 05/2011
1	Brain Neoplasms (Brain Tumor) 12/2022
1	Experimental Melanoma 12/2022
1	Tendon Injuries 10/2022
1	Acute Coronary Syndrome 01/2022
1	Bacteremia 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	COVID-19 11/2021
1	Spinal Dysraphism (Spina Bifida) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2020
1	Multiple Sclerosis 12/2020
1	Hypersensitivity (Allergy) 12/2020
1	Asthma (Bronchial Asthma) 12/2020
1	Triple Negative Breast Neoplasms 11/2020

Drug/Important Bio-Agent (IBA)

22	Biocompatible Materials (Biomaterials)IBA 01/2022 - 03/2003
18	VaccinesIBA 01/2022 - 11/2009
17	HydrogelsIBA 10/2022 - 07/2007
14	AlginatesIBA 01/2021 - 05/2005
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 07/2005
13	AntigensIBA 01/2022 - 02/2009
9	Cancer VaccinesIBA 12/2022 - 10/2011
8	Pharmaceutical PreparationsIBA 10/2019 - 07/2014
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 10/2007
7	PolymersIBA 03/2017 - 01/2009
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2020 - 05/2011
5	CytokinesIBA 12/2022 - 02/2009
4	Biological ProductsIBA 11/2022 - 10/2016
4	Peptides (Polypeptides)IBA 12/2020 - 01/2009
4	Neoplasm Antigens (Tumor Antigens)IBA 11/2020 - 07/2011
4	GelsIBA 11/2020 - 07/2007
3	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2015
3	CryogelsIBA 01/2022 - 08/2015
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2016
3	Polyglactin 910IBA 03/2017 - 08/2013
2	InterferonsIBA 12/2022 - 02/2017
2	Chimeric Antigen ReceptorsIBA 12/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2018
2	ChemokinesIBA 10/2022 - 04/2012
2	OvalbuminIBA 01/2022 - 01/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2020
2	Insulin (Novolin)FDA Link 01/2022 - 01/2017
2	SugarsIBA 12/2020 - 01/2018
2	OligonucleotidesIBA 11/2020 - 09/2011
2	IntegrinsIBA 10/2016 - 01/2009
2	CPG-oligonucleotideIBA 03/2014 - 05/2011
2	Becaplermin (PDGF-BB)FDA Link 02/2010 - 07/2007
1	EnzymesIBA 12/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 12/2022
1	ADU-S100IBA 12/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	micaIBA 01/2022
1	TicagrelorIBA 01/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Purinergic P2Y Receptor AntagonistsIBA 01/2022
1	Immunomodulating AgentsIBA 12/2021
1	polyacrylamideIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	Immunoconjugates (Immunoconjugate)IBA 12/2020
1	SteroidsIBA 12/2020
1	Polysaccharides (Glycans)IBA 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020

Therapy/Procedure

23	Therapeutics 12/2022 - 04/2006
14	Immunotherapy 12/2022 - 01/2011
6	Transplantation 12/2020 - 02/2006
6	Injections 10/2019 - 07/2007
3	Drug Therapy (Chemotherapy) 11/2021 - 10/2007
3	Immunomodulation 01/2020 - 08/2015
2	Stents 04/2015 - 09/2014